Advertisement

Outcome-Driven Thresholds for Pulse Pressure on Office and Out-of-the-Office Blood Pressure Measurement

  • Yumei Gu
  • Lucas S. Aparicio
  • Yanping Liu
  • Kei Asayama
  • Tine W. Hansen
  • Teemu J. Niiranen
  • José Boggia
  • Lutgarde Thijs
  • Jan A. Staessen
Chapter

Abstract

Longitudinal studies demonstrated that the risk of cardiovascular disease increased with pulse pressure (PP). However, PP remains an elusive cardiovascular risk factor with findings being inconsistent between studies. The 2013 ESH/ESC guideline proposed that PP is useful in stratification and suggested 60 mmHg as threshold, moving it up to by 10 mmHg compared with the 2007 guideline without providing any justification. Published thresholds of PP are based on office blood pressure measurement and often on arbitrary categorical analyses. In the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) and in the International Database on Home blood pressure in relation to Cardiovascular Outcome (IDHOCO), we determined outcome-driven thresholds for PP based on ambulatory or home blood pressure measurement, respectively. The main findings are that below age 60 PP does not refine risk stratification, whereas in older people the thresholds were 64 and 76 mmHg for the ambulatory and home PP, respectively. However, PP provided little added predictive value over and beyond classical risk factors.

Keywords

Pulse pressure Thresholds Blood pressure measurement Epidemiology Cardiovascular diseases 

References

  1. 1.
    Staessen J, Amery A, Fagard R. Editorial review. Isolated systolic hypertension. J Hypertens. 1990;8:393–405.PubMedCrossRefGoogle Scholar
  2. 2.
    Bangalore S, Messerli FH, Franklin SS, Mancia G, Champion A, Pepine CJ. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. Eur Heart J. 2009;30:1395–401.PubMedCrossRefGoogle Scholar
  3. 3.
    Madhaven S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395–401.CrossRefGoogle Scholar
  4. 4.
    Greenberg J. Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures. Am J Hypertens. 2005;18:1033–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Domanski MJ, Davis BR, Pfeffer MA, Kastantin M, Mitchell GF. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension. 1999;34:375–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B. Nocturnal blood pressure and 24–hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Liu JH, Chen CC, Wang SM, Chou CY, Liu YL, Kuo HL, Lin HH, Wang IK, Yang YF, Huang CC. Association between pulse pressure and 30-month all-cause mortality in peritoneal dialysis patients. Am J Hypertens. 2008;21:1318–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease change with aging? The Framingham Heart Study. Circulation. 2001;103:1245–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieère P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997;30:1410–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Borghi C, Dormi A, Ambrosioni E, Gaddi A, on behalf of the Brisighella Heart Study working party. Relative role of systolic, diastolic and pulse pressure as risk factors for cardiovascular events in the Brisighella Heart Study. J Hypertens. 2002;20:1737–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Schram MT, Kostense PJ, van Dijk RA, Dekker JM, Nijpels G, Bouter LM, Heine RJ, Stehouwer CD. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens. 2002;20:1743–51.PubMedCrossRefGoogle Scholar
  12. 12.
    Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160:2765–72.PubMedCrossRefGoogle Scholar
  13. 13.
    Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989;13:392–400.PubMedCrossRefGoogle Scholar
  14. 14.
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.PubMedCrossRefGoogle Scholar
  15. 15.
    Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, Grimm R, Cohen J, Stamler J, MRFIT Research Group. Pulse pressure and cardiovascular disease-related mortality. JAMA. 2002;287:2677–83.PubMedCrossRefGoogle Scholar
  16. 16.
    Miura K, Dyer AR, Greenland P, Daviglus ML, Hill MA, Liu K, Garside DB, Stamler J, Chicago Heart Association. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension. 2001;38:232–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Gu YM, Thijs L, Asayama K, Boggia J, Hansen TW, Liu YP, Ohkubo T, Bjorklund-Bodegård K, Jeppesen J, Dolan E, Torp-Pedersen C, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Mena LJ, Wang J, O’Brien E, Verhamme P, Filipovsky J, Maestre GE, Staessen JA, on behalf of the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension. 2014;63:229–37.PubMedCrossRefGoogle Scholar
  18. 18.
    Franklin SS, Gustin 4th W, Wong ND, Larson MG, Weber LA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–15.PubMedCrossRefGoogle Scholar
  19. 19.
    Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.PubMedCrossRefGoogle Scholar
  20. 20.
    Hosmer Jr DW, Leleshow S. Applied logistic regression. New York: Wiley; 1989. p. 47–56.Google Scholar
  21. 21.
    Gillespie BW. Use of generalized R-squared in Cox regression. https://apha.confex.com/apha/134am/techprogram/paper_135906.htm. APHA scientific session and event listing. 2006. Accessed 15 Dec 2013.
  22. 22.
    Aparicio LS, Thijs L, Asayama K, Barochiner J, Boggia J, Gu YM, Cuffaro PE, Liu YP, Niiranen TJ, Ohkubo T, Johansson JK, Kikuya M, Hozawa A, Tsuji I, Imai Y, Sandoya E, Waisman GD, Staessen JA, on behalf of the International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Reference frame for home pulse pressure based on cardiovascular risk in 6470 subjects from 5 populations. Hypertension Res. 2014. Mar 20. doi:  10.1038/hr.2014.45.
  23. 23.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.PubMedCrossRefGoogle Scholar
  24. 24.
    Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker-Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Struijker-Boudier HA, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, O’Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B. 2007 guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462–536.PubMedGoogle Scholar
  25. 25.
    Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.PubMedCrossRefGoogle Scholar
  26. 26.
    Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001;104:783–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Asmar R, Vol S, Brisac AM, Tichet J, Topouchian J. Reference values for clinic pulse pressure in a nonselected population. Am J Hypertens. 2001;14:415–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Yumei Gu
    • 1
  • Lucas S. Aparicio
    • 2
  • Yanping Liu
    • 1
  • Kei Asayama
    • 1
    • 3
    • 4
  • Tine W. Hansen
    • 5
  • Teemu J. Niiranen
    • 6
    • 7
  • José Boggia
    • 8
  • Lutgarde Thijs
    • 1
  • Jan A. Staessen
    • 1
    • 9
  1. 1.Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular SciencesUniversity of LeuvenLeuvenBelgium
  2. 2.Internal Medicine – Hypertension SectionHospital Italiano De Buenos AiresBuenos AiresArgentina
  3. 3.Department of Planning for Drug Development and Clinical EvaluationTohoku University Graduate School of Pharmaceutical SciencesAoba-ku, SendaiJapan
  4. 4.Department of Hygiene and Public HealthTeikyo University School of MedicineItabashi-ku, TokyoJapan
  5. 5.Department of ComplicationsSteno Diabetes CenterGentofteDenmark
  6. 6.Department of Chronic Disease PreventionNational Institute for Health and WelfareTurkuFinland
  7. 7.Department of MedicineTurku University HospitalTurkuFinland
  8. 8.Centro de Nefrología and Departamento de FisiopatologíaHospital de Clínicas, Dr Manuel QuintelaMontevideoUruguay
  9. 9.Department of EpidemiologyMaastricht UniversityMaastrichtThe Netherlands

Personalised recommendations